Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 133

    CDSCO apex committee streamlines drug approval process post clinical trial

    CDSCO apex committee streamlines drug approval process post clinical trial

    Farhat Nasim11 Jun 2019 5:08 PM IST
    New Delhi: In a move to oversee clinical trials on new chemical entities, the Central Drug Standard Control Organisation’s (CDSCO) apex committee has...
    Cipla receives inspection report from USFDA for Kurkumbh facility

    Cipla receives inspection report from USFDA for Kurkumbh facility

    Medical Dialogues Bureau11 Jun 2019 12:02 PM IST
    The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla...
    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Medical Dialogues Bureau11 Jun 2019 9:30 AM IST
    Polivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
    Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

    Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

    Medical Dialogues Bureau11 Jun 2019 9:15 AM IST
    The growth would primarily better revenues from its drug Copaxone as projected by Natco Pharma's marketing partner Mylan and also improved performance...
    Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

    Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

    Medical Dialogues Bureau11 Jun 2019 9:00 AM IST
    The filing in U.S. Bankruptcy Court in the District of Delaware made Insys Therapeutics the first drug manufacturer to turn to bankruptcy due to legal...
    Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo

    Relief for JnJ: Central Drugs Laboratory reaffirms safety of JnJ baby shampoo

    Farhat Nasim10 Jun 2019 3:51 PM IST
    The Central Drugs Laboratory in Kolkata conducted tests on two different lots of the JnJ baby shampoo after the company contested a finding of the...
    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Farhat Nasim10 Jun 2019 2:02 PM IST
    The detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Farhat Nasim10 Jun 2019 9:30 AM IST
    Roche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
    Merck, Rigaku partner to develop novel molecular structure analysis technology

    Merck, Rigaku partner to develop novel molecular structure analysis technology

    Farhat Nasim10 Jun 2019 9:15 AM IST
    The partnership creates an outstanding strategic opportunity for both companies, Merck and Rigaku to establish leading products for chemical...
    GSK Nucala wins USFDA approval for two new self-administration options

    GSK Nucala wins USFDA approval for two new self-administration options

    Farhat Nasim9 Jun 2019 10:00 AM IST
    Nucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Medical Dialogues Bureau9 Jun 2019 9:30 AM IST
    In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Farhat Nasim9 Jun 2019 9:25 AM IST
    Marie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok